WELCOME TO XBIOTECH

XBiotech is working to provide safer and more effective medication to patients through the use of True Human™ antibodies. Our lead product candidate blocks chronic inflammation and represents a possible breakthrough in the treatment of many debilitating diseases—including cancer, diabetes, psoriasis and vascular disease. We are working to change the future of medicine.

NEWS

divider

12.05.11

XBiotech Presents Oncology Trial Results -

XBiotech recently presented results from its oncology program at the AACR-NCI-EORTC…more

divider

09.24.11

XBiotech Hosts Clinical Investigators -

XBiotech hosted its clinical investigators in vascular disease over the weekend at a conference…more

divider

09.12.11

Early Results from XBiotech’s Clinical Study in Cachexia… -

Since February 2010, XBiotech has been studying the effects…more

divider

08.30.11

XBiotech Launches Partnership Talks in Asia -

XBiotech believes its lead product candidate offers unprecedented…more